Skip to content

Drug interactions

Imatinib + Lapatinib

Severity: Moderate

Imatinib and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits P-glycoprotein and CYP3A4 and may raise imatinib concentrations. Lapatinib is also a CYP3A4 substrate that imatinib may affect, so both drugs' exposure may rise.

What this interaction means in plain words

Imatinib and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein and CYP3A4 by lapatinib reduces imatinib efflux and clearance.

What to do

Monitor for imatinib toxicity such as edema, cytopenias and liver enzyme elevation, and for lapatinib toxicity including diarrhea and QT prolongation. Reduce doses if adverse effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Lapatinib?

MediHelp rates the interaction as moderate. Imatinib and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib inhibits P-glycoprotein and CYP3A4 and may raise imatinib concentrations. Lapatinib is also a CYP3A4 substrate that imatinib may affect, so both drugs' exposure may rise.

How serious is the interaction between Imatinib and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for imatinib toxicity such as edema, cytopenias and liver enzyme elevation, and for lapatinib toxicity including diarrhea and QT prolongation. Reduce doses if adverse effects occur.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in